The Effect of Four Approaches to Treat Actinic Keratosis on the Health-Related QOL, as Assessed by the Skindex-29 and Actinic Keratosis QOL

J Invest Dermatol. 2021 Jul;141(7):1830-1832. doi: 10.1016/j.jid.2020.12.023. Epub 2021 Jan 18.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aminolevulinic Acid / administration & dosage
  • Aminolevulinic Acid / analogs & derivatives
  • Diterpenes / administration & dosage
  • Female
  • Fluorouracil / administration & dosage
  • Humans
  • Imiquimod / administration & dosage
  • Keratosis, Actinic / diagnosis
  • Keratosis, Actinic / drug therapy*
  • Male
  • Patient Reported Outcome Measures*
  • Photochemotherapy / methods
  • Quality of Life*
  • Skin Cream / administration & dosage
  • Surveys and Questionnaires / statistics & numerical data
  • Treatment Outcome

Substances

  • 3-ingenyl angelate
  • Diterpenes
  • methyl 5-aminolevulinate
  • Aminolevulinic Acid
  • Imiquimod
  • Fluorouracil

Associated data

  • ClinicalTrials.gov/NCT02281682